Related Experiment Video
Updated: Jan 7, 2026

Assessment of Bone Fracture Healing Using Micro-Computed Tomography
Published on: December 9, 2022
Individual and Community-level Determinants of Osteoporosis Treatment Following Fracture Among Medicare Beneficiaries
Hongke Wu1,2, Ye Liu3,4, Jingyi Zhang1,2
1University of Alabama at Birmingham, Birmingham, AL, USA.
Background:
Despite guideline recommendations, pharmacologic treatment after osteoporotic fracture remains suboptimal.
Objective:
To identify individual and community factors associated with osteoporosis (OP) treatment after major osteoporotic fracture, and to investigate osteoporosis treatment patterns before and after fracture.
Design:
Retrospective cohort study using a 5% random sample of Medicare fee-for-service claims (2016-2021).
Participants:
Medicare beneficiaries ≥ 65 years with a first major osteoporotic fracture (hip, vertebral, pelvis, humerus, femur, or radius/ulna) during 2017-2020 and ≥ 12 months of continuous enrollment before the index fracture.
Main Measures:
Primary outcome of interest was the start of any OP medication (bisphosphonates, denosumab, teriparatide, abaloparatide, or romosozumab) within one year after fracture. Key factors included preventive-service use in the prior year, community social determinants of health (SDoH) factors derived by exploratory factor analysis, and individual demographics and comorbidities. Lasso-penalized Cox models selected essential variables and estimated adjusted hazard ratios (HRs).
Key Results:
Only 11.9% of patients were treated before fracture and 77.6% received no treatment both before and after fracture. Preventive services were associated with increased post-fracture OP treatment in both sexes (Wellness visit HR[95%CI] = 1.20[1.04-1.38] in men, 1.02[0.98-1.07] in women, bone mineral density testing HR = 1.57[1.28-1.94] in men, 1.15[1.09-1.22] in women; influenza/pneumococcal vaccination HR = 1.28[1.09-1.49] in men, 1.13[1.08-1.19] in women). A community "socioeconomic barrier" factor (low income, high poverty, high mobile-home residence, uninsured) was associated with decreased post-fracture OP treatment in women (HR = 0.89[0.81-0.98]) but not in men. Antidepressant use and history of falls were associated with decreased post-fracture OP treatment in both sexes.
Conclusions:
OP treatment after fracture remains suboptimal-especially among men-despite clear guidelines. Engagement with preventive care was strongly associated with treatment initiation. Community socioeconomic disadvantage and depression were also important barriers to post-fracture treatment, with sex-specific patterns. Integrating fracture-care pathways into preventive visits and focusing on socioeconomically disadvantaged communities could improve secondary fracture prevention.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Bone Remodeling
Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
